Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GAD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
COL19A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACTN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EDDM3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HAS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC23A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ADGRB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP26-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
GTF2IRD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101928818 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRCD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAS2R50 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLEC4G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIDN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on